Back

Lp(a) rarely coexists without coronary atherosclerosis

31 August 2026 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Acute coronary syndromes: biomarkers and clinical outcomes Biomarkers ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Ian Chapman

Instituto Cardiovascular De Buenos Aires, Buenos Aires (Argentina)

6 More presentations in this session

Presentation thumbnail
Incremental prognostic value of a cardio-renal-inflammatory biomarker triad for early mortality prediction in acute coronary syndromes
Doctor H. Bendoudouch (Tangier, MA)
Abstract Slides
Presentation thumbnail
Lp a and CAC score 0: the hidden risk phenotype
Doctor M. Viruel (Buenos Aires, AR)
Abstract Slides
Presentation thumbnail
Elevated lipoprotein(a) is associated with increased inflammatory and myocardial injury markers in acute coronary syndrome patients undergoing percutaneous coronary intervention
Doctor Z. Horvath (Budapest, HU)
Abstract Slides
Presentation thumbnail
Lipid risk profile in ACS in young women: contribution of Lp(a) measurement: ancillary analysis of the WAMIF study
Doctor S. Manzo-Silberman (Paris, FR)
Abstract Slides
Presentation thumbnail
Acute-phase versus post-stabilisation lipoprotein(a) levels in patients with acute myocardial infarction: a paired analysis
Doctor D. Matos Monteiro (Coimbra, PT)
Abstract Slides

Access the full session

Session thumbnail
Acute coronary syndromes: biomarkers and clinical outcomes

The Event

Event poster

ESC Congress 2026

31 August 2026 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Sex-specific influence of lipoprotein(a) levels on coronary plaque characteristics: the COPRODUCTION-registry
1 September 2025
thumbnail
Congress Presentation
Biologic significance of healed culprit plaques in stable angina versus acute coronary syndromes
31 August 2019
thumbnail
Webinar
Update on dyslipidaemia management: focus on risk estimation and lipoprotein(a)
7 October 2025
thumbnail
Congress Session
Lp(a), triglycerides and coronary artery disease
28 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources